You have no items in your shopping cart.
Search results for: 'FGF'
FGF-1 Protein, Canine, Recombinant [orb1956091]16 kDa (predicted); 16 kDa (reducing conditions)
100 μg- FGF-17 Protein, Human, Recombinant [orb1956593]
99.20%
22.6 kDa (predicted); 21 and 23 kDa (reducing conditions)
200 μg, 20 μg, 100 μg - FLRT1 Protein, Human, Recombinant (His) [orb1957633]
57 kDa (predicted); 65 kDa (reducing condition, due to glycosylation)
100 μg - FGF-21 Protein, Mouse, Recombinant (His) [orb1957527]
93.00%
21.3 kDa (predicted); 25 kDa (reducing condition, due to glycosylation)
50 μg, 1 mg - FGF-21 Protein, Human, Recombinant (His) [orb1957765]
20.2 kDa (predicted); 23 kDa (reducing conditions)
1 mg, 50 μg - FGF-18 Protein, Human, Recombinant (His) [orb1957061]
98.40%
22.3 kDa (predicted); 32 kDa (reducing condition, due to glycosylation)
50 μg, 100 μg, 200 μg - FGF-1 Protein, Mouse, Rat, Recombinant [orb1958530]
95.60%
16 kDa (predicted); 16 kD (reducing conditions)
1 mg, 10 μg, 100 μg - FGF-10 Protein, Human, Recombinant [orb1958555]
SDS-PAGE: 97.9%; SEC-HPLC: 98.9%
19.46 kDa (predicted); 19.46 kDa (reducing conditions)
20 μg, 100 μg - FLRT3 Protein, Human, Recombinant (His) [orb1958203]
58 kDa (predicted); 60-70 kDa (reducing condition, due to glycosylation)
100 μg - FGF-18 Protein, Mouse, Recombinant (His) [orb1958225]
> 95 % as determined by SDS-PAGE
22.5 kDa (predicted); 30-35 kDa (reducing condition, due to glycosylation)
50 μg, 1 mg